Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 1201 AL 1215

Beyond the amyloid hypothesis: how current research implicates autoimmunity in Alzheimer's disease pathogenesis

Chatanaka MK, Sohaei D, Diamandis EP, Prassas I.

Crit Rev Clin Lab Sci. 2023 Sep;60(6):398-426. doi: 10.1080/10408363.2023.2187342. Epub 2023 Mar 20.

A systematic review of the association between dementia risk factors and cerebrovascular reactivity

Wang C, Reid G, Mackay CE, Hayes G, Bulte DP, Suri S.

Neurosci Biobehav Rev. 2023 May;148:105140. doi: 10.1016/j.neubiorev.2023.105140. Epub 2023 Mar 20.

Validity of Normative Volumetric Estimates from Open Access Software in Amnestic Mild Cognitive Impairment

Fountain-Zaragoza S, Horn O, Thorn KE, Kraal AZ, Benitez A.

J Prev Alzheimers Dis. 2023;10(2):236-243. doi: 10.14283/jpad.2023.19.

Medical and Psychiatric Risk Factors for Dementia in Veterans with and without Traumatic Brain Injury (TBI): A Nationwide Cohort Study

Gardner RC, Barnes DE, Li Y, Boscardin J, Peltz C, Yaffe K.

J Prev Alzheimers Dis. 2023;10(2):244-250. doi: 10.14283/jpad.2023.16.

The Association Between Cardiovascular Disease and Dementia: A Review of Trends in Epidemiology, Risk Factors, Pathophysiologic Mechanisms, and Clinical Implications

Pandit M, Frishman WH.

Cardiol Rev. 2024 Sep-Oct 01;32(5):463-467. doi: 10.1097/CRD.0000000000000523. Epub 2023 Mar 22.

New insights toward molecular and nanotechnological approaches to antidiabetic agents for Alzheimer's disease

Pradhan SP, Sahu PK, Behera A.

Mol Cell Biochem. 2023 Dec;478(12):2739-2762. doi: 10.1007/s11010-023-04696-1. Epub 2023 Mar 22.

Delirium and Dementia in the Elderly: Sometimes Associated or Always Together?

Bugiani O.

Eur Neurol. 2023;86(3):161-165. doi: 10.1159/000530226. Epub 2023 Mar 23.

Natural language processing techniques for studying language in pathological ageing: A scoping review

Gagliardi G.

Int J Lang Commun Disord. 2024 Jan-Feb;59(1):110-122. doi: 10.1111/1460-6984.12870. Epub 2023 Mar 24.

Editorial: Association of metabolic diseases with cognition impairment and dementia

Luan S, Zhou J.

Front Endocrinol (Lausanne). 2023 Mar 10;14:1166342. doi: 10.3389/fendo.2023.1166342. eCollection 2023.

The Future of Cognitive Screening in Neurodegenerative Diseases

Umfleet LG, Bilder RM, Loring DW, Thames A, Hampstead BM, Bauer RM, Drane DL, Cavanagh L.

J Alzheimers Dis. 2023;93(1):47-59. doi: 10.3233/JAD-221077.

Insulin-like growth factor-2 is a promising candidate for the treatment and prevention of Alzheimer's disease

Fitzgerald GS, Chuchta TG, McNay EC.

CNS Neurosci Ther. 2023 Jun;29(6):1449-1469. doi: 10.1111/cns.14160. Epub 2023 Mar 27.

New Pathways Identify Novel Drug Targets for the Prevention and Treatment of Alzheimer's Disease

Penke B, Szűcs M, Bogár F.

Int J Mol Sci. 2023 Mar 11;24(6):5383. doi: 10.3390/ijms24065383.

Dietary Protection against Cognitive Impairment, Neuroinflammation and Oxidative Stress in Alzheimer's Disease Animal Models of Lipopolysaccharide-Induced Inflammation

Decandia D, Gelfo F, Landolfo E, Balsamo F, Petrosini L, Cutuli D.

Int J Mol Sci. 2023 Mar 21;24(6):5921. doi: 10.3390/ijms24065921.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias